Deferiprone reduces hemosiderin deposits in the brain of a patient with superficial siderosis

Michael Levy, R. H. Llinas

Research output: Contribution to journalArticle

Abstract

SUMMARY: A man with superficial siderosis showed improvement in symptoms and reduction in hemosiderin by MR imaging following treatment with deferiprone, a lipid-soluble iron chelator.

Original languageEnglish (US)
Pages (from-to)E1-E2
JournalAmerican Journal of Neuroradiology
Volume32
Issue number1
DOIs
StatePublished - Jan 1 2011

    Fingerprint

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology

Cite this